A Study of IBI3032 in Chinese Healthy Subjects

NCT07134127 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: placebo
DRUG: IBI3032

Sponsor

Innovent Biologics Technology Limited (Shanghai R&D Center)